This $180,059 Project Grant award was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research by the Research Institute at Nationwide Children's Hospital (RINCH) to identify positive childhood experiences (PCEs) that can promote optimal developmental outcomes in children with a history of neonatal opioid withdrawal syndrome (NOWS).
The key products and services to be delivered under this 5-year award...
The U.S. Executive Office of the President's Office of the National Drug Control Policy awarded a $175,371.50 Project Grant (CFDA 95.010 - Congressional Directives) to Kidsafe Collaborative, Inc. (operating as Community Network For Children Youth & Families), a non-profit organization in Burlington, Vermont. The grant, titled "CHILDREN AND RECOVERING MOTHERS CHARM," supports the organization's substance use disorder prevention, treatment, and community-based health initiatives,...
Child Protect of Mercer County, Inc. will use a $739,322 project grant award from the Department of Justice Office of Justice Programs Office of Juvenile Justice and Delinquency Prevention to develop coordinated prevention and intervention strategies for youth and families impacted by opioids and other substances in Princeton, West Virginia. The funding supports the Opioid Affected Youth Initiative program and will allow Child Protect to provide mentoring, trauma-focused therapy, and...
The U.S. Department of Health and Human Services, through the Substance Abuse and Mental Health Services Administration (SAMHSA) Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, awarded a $400,000 Project Grant to the County of Pinellas, Florida to enhance substance use disorder (SUD) treatment and recovery support services for drug-involved parents in Pinellas County over a 5-year period from 2024-2029.
The grant funding will...
This $6,439,263 federal Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 Drug Abuse and Addiction Research Programs) aims to determine the impact of maternal substance use on maternal immune activation, placental function, and offspring neurobehavioral development. The project will leverage the Healthy Brain and Child Development (HBCD) study to perform maternal immune profiling, placental and cord blood analysis, and novel neuroinflammation imaging on 400...
The federal Project Grant award K23DA061933, titled "Promoting Positive Parenting for Mothers with OUD: Implementation of a Video-Coaching Intervention in Pediatrics," is funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $193,752 award supports research to test the effectiveness of a video-coaching intervention called THRIVE in promoting responsive parenting behaviors and improving psychosocial functioning...
The Department of Health & Human Services North Carolina, Martin-Tyrrell-Washington District Health Department Division, received a $734,285 Project Grant from the Department of Justice's Comprehensive Opioid, Stimulant, and other Substances Use Program (COSSUP, CFDA 16.838). The grant will fund the operation of a Family-Centered Drug Treatment Court that uses a collaborative, trauma-informed approach to address parental substance use disorders and child welfare. The goal is to reduce...
This federal Project Grant award of $1,499,606.00 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to characterize health outcomes and identify disparities in children born to people with opioid use disorder (OUD) from birth to 5 years of age. The study will utilize data from the Texas Neonatal Care Research Collaborative to:
Examine variation in the diagnosis of neonatal opioid withdrawal syndrome (NOWS) across hospitals and identify...
The Massachusetts General Hospital (MGH) Substance Use Disorder Initiative is a $749,939 Project Grant awarded by the U.S. Department of Justice Office of Juvenile Justice and Delinquency Prevention under the Opioid Affected Youth Initiative (CFDA 16.842). The initiative will provide multidisciplinary, trauma-informed, dyadic-based, longitudinal medical and mental healthcare at MGH's HOPE Clinic, aimed at reducing the intergenerational transmission of substance use and minimizing future...
This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,464,467 to Baystate Medical Center, Inc. to conduct a Type I Hybrid Effectiveness-Implementation Trial of the "Mothering from the Inside Out" (MIO) intervention. MIO is an attachment-based parenting program for mothers with substance use disorders, targeting parental reflective functioning to improve maternal caregiving, child...